For a stock that had been struggling for significance for much of the past year, this dramatic shift was not merely a rally — ...
Pharmaceutical Technology on MSN
Gilead Sciences to acquire Repare’s RP-3467
Gilead will pay Repare $25m upfront, and up to an additional $5m upon completion of certain technology transfer activities.
SPARC Kips Bay will provide modern facilities for 4,500 City University of New York students and create a clear pathway to ...
Austin-based Cassava Sciences has reached a settlement agreement in a years-long investor lawsuit that centered on ...
In order to make medical school more affordable and accessible while addressing the state's shortage of health care ...
Partnerships with giants like Eli Lilly and Thermo Fisher Scientific put biotech in the spotlight again, though founders still struggle to find investments in their hometown.
WEST LAFAYETTE, Ind. — Amplified Sciences, a clinical-stage life sciences diagnostic company that develops tests for early, more accurate detection of challenging diseases, starting with pancreatic ...
As of Friday, December 19, Cassava Sciences, Inc.’s SAVA share price has dipped by 17.37%, which has investors questioning if this is right time to buy.
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Keeley Wettan will be appointed Executive Vice President, General ...
Struggles at Alexandria Real Estate Equities portend more challenges for the life sciences real estate market.
Governor Shapiro speaking alongside county and state leaders today at the University of Pittsburgh's Assembly building. It's *** space he says is *** hub for life sciences, and he highlighted *** $50 ...
Cassava Sciences (SAVA) reached a definitive agreement to resolve the previously disclosed consolidated securities class action litigation pending ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results